Skip to content

Current shortage

ONCOTICE BCG 5 hundred million CFU powder for injection vial

Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain) · 200000000 CFU Injection, powder for

Supply impact started
1 Jan 2019
Supply impact ends
31 Dec 2027
TGA row last updated
14 Sept 2026
ARTG ID
59912
Sponsor
Merck Sharp & Dohme (Australia) Pty Ltd
Sponsor phone
1800818553
Shortage impact
Critical
Availability
Limited Availability

Reason reported to TGA

Unexpected increase in consumer demand

TGA management action

An overseas-registered product has been approved for supply under section 19A. The approval holder, Link Medical Products Pty Ltd, can be contacted for details on supply on 1800 181 060.

What to do

  1. 1.
    Contact your pharmacist — Your pharmacist can check stock and whether another pharmacy can supply this product.
  2. 2.
    Ask your doctor before switching — A prescriber can decide whether another product is appropriate. Do not change medicines on your own.
  3. 3.
    Check the TGA report — The TGA Medicine Shortage Reports Database is the source for the dates and management action on this page.

Official sources

Last updated from the TGA Medicine Shortage Reports Database (report generated 12 November 2026 10:24:39 PM).

TGA Medicine Shortage Reports Database

PBS schedule — Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain)

MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.